Vigilant Biosciences Raises $10.5M in Series B Round July 11, 2016 Vigilant Biosciences, an oral cancer testing company, announced that it has raised a total

Vigilant Raises $5M to Commercialize Oral Cancer Test July 11, 2016 Vigilant Biosciences has raised $5 million to commercialize OncAlert, its oral cancer detection test.

Vigilant Biosciences Announces Three New OncAlert Distribution Agreements for Europe, Africa, and Latin America June 15, 2016 The new OncAlert agreements will further expand Vigilant

From the Editor: Liquefaction, Dx Style June 7, 2016 When technologies have matured to the point of market readiness, it can be hard to keep

Oral Rinse Test Picks Up Early-Stage Oral Cancer June 7, 2016 An inexpensive oral rinse test has been shown to distinguish head and neck cancer

Early Detection of Head and Neck Cancer Gets a Boost: Vigilant Biosciences Launches First-of-its-kind OncAlert Labs OraMark Test in the United States June 6, 2016